Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Preferred Stock Liabilities: 2012-2018

Historic Preferred Stock Liabilities for UNITED THERAPEUTICS (UTHR) over the last 7 years, with Dec 2018 value amounting to $19.2 million.

  • UNITED THERAPEUTICS's Preferred Stock Liabilities fell 56.25% to $8.4 million in Q2 2019 from the same period last year, while for Jun 2019 it was $8.4 million, marking a year-over-year decrease of 56.25%. This contributed to the annual value of $19.2 million for FY2018, which is negligibly% changed negligibly from last year.
  • According to the latest figures from FY2018, UNITED THERAPEUTICS's Preferred Stock Liabilities is $19.2 million, which was down 0.00% from $19.2 million recorded in FY2017.
  • UNITED THERAPEUTICS's 5-year Preferred Stock Liabilities high stood at $23.2 million for FY2014, and its period low was $10.9 million during FY2016.
  • Over the past 3 years, UNITED THERAPEUTICS's median Preferred Stock Liabilities value was $19.2 million (recorded in 2018), while the average stood at $16.4 million.
  • Per our database at Business Quant, UNITED THERAPEUTICS's Preferred Stock Liabilities tumbled by 52.19% in 2015 and then soared by 76.15% in 2017.
  • UNITED THERAPEUTICS's Preferred Stock Liabilities (Yearly) stood at $23.2 million in 2014, then crashed by 52.19% to $11.1 million in 2015, then decreased by 1.80% to $10.9 million in 2016, then spiked by 76.15% to $19.2 million in 2017, then remained steady at $19.2 million in 2018.